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expressed gene was PLK1 by 12 times, and was also found to be
over-expressed in Huh-7 cells. SiRNA against PLK-1 validated by
real-time PCR (RTPCR) and Western Blotting showed a reduction
of PLKR1 expression up to 96% in huh-7 cells, and reduced cell
proliferation by 68% and 92% in MTS and BrdU cell proliferation as-
says respectively. There was 3-fold increase in apoptosis events,
and TUNEL staining and caspase-3 assays suggested that this may
be caspase-independent. The pan-caspase inhibitor Z-VAD-FMK
was unable to rescue apoptotic cells. Immnoﬂuorescence studies
co-localised endonuclease G to fragmented chromosomes, thus
was postulated to be the main apoptotic effector. Knockdown
of the FOXM1 transcription factor, thought to be a positive reg-
ulating factor did not affect PLK1 gene expression, suggesting
other transcription factors may be important. Finally, huh-7 cells
transplanted subcutaneously into nude mice using matrigel were
treated with si-PLK1 and control si-RNA. Tumour regression of
33% occurred in the mice treated with si-PLK1 but not in controls.
Conclusion: PLK1 overexpression in HCC was shown to be func-
tionally important by gene silencing experiments, and may be a
potential therapeutic target.
Concurrent Session 16 – Global Monster – MRSA
CS16-01 A Work in Progress: MRSA and cMRSA in Latin
America
Raul E. Isturiz *. Department of Medicine, Infectious Diseases,
Centro Medico de Caracas, Caracas, Venezuela
MRSA is the leading cause of nosocomial infection in Latin Amer-
ica, and the number of reports of community-acquired (cMRSA)
infections continue to rise.
The full extent of the problem is unknown because surveillance
information is only available from large hospitals, while much
of the population is cared for in small centers that do not per-
form microbiological testing or use different methodology and
deﬁnitions. Under these conditions, monitoring the epidemiology
of MRSA remains a challenge and there is a need to improve
detection and management.
Nosocomial, multidrug-resistant MRSA is a growing problem in
Latin America with estimated prevalence for the region currently
near or above 50% for non blood stream infections and over 40%
for bacteremia.
Reports of CA-MRSA infections initially came from Brazil in 2003.
Soon, a large outbreak of CA-MRSA infection that affected in-
mates in jails and people from the community in Uruguay was
described; more than 1000 patients were affected and 12 died.
In the region SSTIs account for the majority of cases, but severe
forms of pneumonia were reported, including 4 deaths. In this
outbreak, TMP-SMX remains active in vitro and is used for the
treatment of skin infections.
Interestingly, an apparent decrease in MRSA strains with van-
comycin MIC greater or equal to 1 μg/ml suggests a shift in clonal
dissemination, and further data are required to follow this trend,
which may have important implications for treatment.
Although surveillance systems in Latin America are improving,
many limitations remain.
CS16-02 Elucidating Geographical Spread of Methicillin-
Resistant Staphylococcus aureus (MRSA): From
Molecular Typing, Multilocus Sequence Typing to
Microbial Genomics
Margaret Ip*. Dept of Microbiology, Chinese University of Hong
Kong, Prince of Wales Hospital, Shatin, Hong Kong
Methicillin-resistant Staphylococcus aureus (MRSA) is a leading
cause of hospital-acquired infections and an increasingly recog-
nized pathogen from the community worldwide. MRSA infections
are associated with high morbidity and mortality, and are a major
ﬁnancial burden to healthcare globally.
A number of typing methods, including pulsed-ﬁeld gel elec-
trophoresis (PFGE), has been used by international surveillance
networks to study the relationships and spread of MRSA iso-
lates geographically. It was established that the large majority
of MRSA isolates belong to a limited set of epidemic clones
worldwide, namely the Brazilian, Iberian, New York/Japan, Pae-
diatric clones. Methicillin resistance is conferred by the penicillin
binding protein PBP2’, encoded by the mecA gene, present in
a large fragment of mobile DNA designated “staphylococcal
cassette chromosome”, SCCmec. More recently, sequence-based
methods have been employed in the analyses of these isolates.
Multilocus sequence typing (MLST) requires the sequence de-
termination of internal fragments of 7 housekeeping genes for
each strain. Each identical sequence is assigned an allele num-
ber, and the combination of alleles at each locus deﬁnes its
sequence type (ST). The combination of MLST and SCCmec typing
applied on international collections of MRSA revealed that these
epidemic MRSA clones emerged on repeated acquisition (over
20 times) of SCCmec by successful methicillin-susceptible S.
aureus (MSSA) clones belonging to ﬁve phylogenetically distinct
lineages or clonal complexes (CCs): CC8, CC5, CC45, CC22 and
CC30.
MRSA is endemic in Hong Kong hospitals. Our previous study
on MRSA causing bacteremia in Hong Kong hospitals belonged
to four clonal complexes CC5, CC45, CC49 and CC239. The
most prevalent MRSA clone in Hong Kong belonged to CC239,
with PFGE types A-E, and H, SCCmec type III, and belonged to
sequence type, ST239, with a multidrug resistance proﬁle to
tetracycline (T), erythromycin (E), clindamycin (D), gentamicin
(G), tobramycin (To) and ciproﬂoxacin (Ci). Evidence also sup-
ports the prevalence of CC239 in Asian countries including China,
Singapore, Taiwan, and Indonesia, whereas MRSA strains from
Korea and Japan belonged to CC5 that had SCCmec type II.
With advances in sequencing technology, the evolutionary history
of the MRSA clone ST5 was further studied by mutation discovery
at 108 loci (46kb) within a global collection. Sequence polymor-
phisms in 1.6% (46,483 bp) of the genome from each MRSA strain
was screened. The SNPS deﬁned a radial phylogenetic structure
within ST5 consisting of at least 5 chains of mutational steps that
deﬁne geographically associated clades. Mapping of the indepen-
dent imports of the SCCmec demonstrated import occurred at
least 23 occasions, and that the progeny of such recombinant
strains are locally rather than globally. This further exempliﬁes
that geographical spread of MRSA over long distances and across
cultural borders is a rare event compared with the frequency
with which SCCmec has been imported.
CS16-03 Molecular Characteristic of
Community-Acquired, Methicillin-Resistant
Staphylococcus aureus
Xuzhuang Shen*. Education Department, Beijing Children’s
Hospital Afﬁliated to Capital Medical University, Beijing, China
MRSA became the most common nosocomial pathogen in many
hospitals since the 1980s, especially in many Asian countries. Epi-
demiologic reports showed that >50% of S. aureus isolates from
the hospitals in Korea, Japan, Taiwan, Hong Kong, Singapore,
and Sri Lanka were MRSA. MRSA infection is now increasingly
reported in the community. According to the ANSORP study from
2004 to 2006 in 9 Asian countries, the prevalence of MRSA among
community-associated S. aureus isolates was 20.8% in Asian re-
gion and it was the highest in Taiwan (40.5%), followed by Sri
Lanka (38.8%), the Philippines (30.1%), and Vietnam (28.2%).
Skin and soft tissue infection was the most common infection by
community-associated MRSA (CA-MRSA) followed by respiratory
tract infection and primary bacteremia. CA-MRSA isolates from
Asian region showed diverse microbiologic and genetic features
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with regard to in vitro resistance, SCCmec type, frequency of pvl
gene and MLST type.
There have rare report about molecular characteristic of CA-
MRSA infections in children from China, this prospective study
was undertaken in order to characterize the molecular char-
acteristic of CA-MRSA in children in China. We collected 99
CA-MRSA isolates from 8 hospitals in 7 cities in China between
2008 and 2009. All isolates were analysed by a combination of
different genotyping methods, including MLST, SCCmec type, and
spa typing, pvl gene was also detected.
In all of the CA-MRSA isolates, twelve STs were obtained, and
ST59 (58.6%) was the most prevalent type throughout China.
SCCmec type IV (67.7%) was the most popular type, and sub-
types IVa, IVc, IVg were found in 77.6%, 11.9%, 2.9% of those
isolates respectively. Eleven spa types were identiﬁed, and four
new spa types were ﬁrstly registered on the net in our ﬁndings.
ST59-SCCmec IVa with t437, was the most prevalent clone. In
addition, 57.6% of those isolates were PVL positive. CA-MRSA iso-
lates were found to be resistant to non-β-lactam antimicrobial,
and multidrug resistance was observed in 85.9% of them.
In conclusion, the recent increase in CA-MRSA infections in
children of China is largely associated with the spread of the
ST59-SCCmec IVa with t437 clone and the multiresistant rate is
high.
Concurrent Session 17 – End Stage Liver Diseases and
Complications
CS17-01 Management of Hepatitis Related Liver Cirrhosis
(TBC)
Yuming Wang*. Institute of Infectious Diseases of PLA,
Southwest Hospital, Third Military Medical University,
Chongqing, China
CS17-02 Non-Invasive Assessment of Liver Fibrosis and
Cirrhosis
Hong You*. Liver Center, Beijing Friendship Hospital, Capital
Medical University, Beijing, China
Fibrosis is a frequent, life-threatening complication of most
chronic liver diseases. Up to now liver biopsy is still the gold stan-
dard for assessment of hepatic ﬁbrosis and cirrhosis. However, it
is invasive with possible complications, costly and afﬂicted with
a high degree of sampling error. There is a strong demand for
reliable, liver speciﬁc, non-invasive biomarkers of ﬁbrosis and
cirrhosis to replace or to complement the invasivemethod of nee-
dle biopsy. Class I biomarkers are deﬁned as serum components
which reﬂect ECM turnover (ﬁbrogenesis and ﬁbrolysis) and ﬁ-
brogenic cell changes, mainly of hepatic stellate cells, which are
the dominant proﬁbrogenic cell type in liver. The development of
hepatic ﬁbrosis or cirrhosis is due to increased synthesis, depo-
sition, and possibly reduced degradation of hepatic extracellular
matrix components, especially collagens, such as interstitial type
I and III, basement membrane type IV, microﬁbrillar type VI, and
pericellular type V, non-collagenous proteins, such as laminin,
ﬁbronectin, undulin, etc. Class II biomarkers comprise in general
rather simple standard laboratory tests, which are grouped into
panels. Class II biomarkers are based on algorithmic evaluation
of commonly observed functional alterations of the liver that
do not necessarily reﬂect ECM metabolism and/or ﬁbrogenic
cell changes. About 20 numerical scores or indices are reported
for parameters, which are mostly routine laboratory tests and
frequently multiparametric (panels). They fulﬁl most criteria for
detection and staging of ﬁbrosis and to a lesser extent grading of
ﬁbrogenic activity. The Fibrotest is the most investigated com-
bination of serum markers for ﬁbrosis. However, the diagnostic
use of many of these scores is still limited and standardization
of the assays is only partially realized. Transient elastography
(Fibroscan), which measures the stiffness of the liver by means
of ultrasound as a measure of ﬁbrosis and cirrhosis, is simple to
perform and the inter- and intra-observer variability is small. The
accuracy is high in discriminating between cirrhosis and ﬁbrosis,
but lower for discriminating between the different stages of
ﬁbrosis in both chronic hepatitis B and C. All the makers of liver
ﬁbrosis can be combined for a better diagnosis.
CS17-03 Clinical Implications of Spontaneous Bacterial
Peritonitis Due to Antibiotic-Resistant
Microorganism
Kyoung-Ho Song*. Division of Infectious Diseases, Department of
Internal Medicine, Seoul National University Bundang Hospital,
Seongnam, Korea
Background: Spontaneous bacterial peritonitis (SBP) is a major
cause of morbidity and mortality in cirrhosis patients. Gram neg-
ative bacilli, such as Escherichia coli and Klebsiella species (EK)
are the most common cause of SBP. Recently, infections due to
antibiotic-resistant microorganism have increased, especially by
extended-spectrum β-lactamase-producing EK (ESBL-EK). How-
ever, among SBP in patients with advanced liver cirrhosis, the
impacts of antibiotic-resistant (including ESBL-producing) organ-
isms on clinical outcome and risk factors for infection have not
been well focused.
Aims & Methods: Electronic searches in MEDLINE and EMBASE
about SBP in patients with advanced liver cirrhosis were per-
formed to elucidate clinical implications of SBP due to antibiotic-
resistant microorganism.
Results: SBP due to microorganism which was resistant to third
generation cephalosporin accounted for 5∼15%. SBP due to
antibiotic-resistant organism had poorer outcome than SBP by
antibiotic-susceptible strain. Especially, 30-day mortality of SBP
due to ESBL-EK was very high (about 50%). And the risk factors for
the development of infection with antibiotic-resistant organisms
that have been listed in several studies are: underlying severe
hepatic dysfunction, nosocomial infection, longer hospital stay
and ICU stay, presence of indwelling vascular catheter, prior
administration of an antibiotic and higher severity of illness.
Although the impact of a delay in effective initial treatment
was controversial, several studies suggest that ineffective initial
therapy may be a cause of the higher mortality.
Conclusions: SBP due to antibiotic-resistant organism had higher
mortality than SBP by susceptible strain and ineffective initial
therapy may be a cause of the higher rates of treatment failure
and mortality. Therefore, it would seem reasonable to treat
patients with SBP due to antibiotic-resistant organism with ef-
fective antibiotics straight away. However, the injudicious use of
broad antimicrobial regimens is likely to result in further emer-
gence of resistance. To promote the prudent use of antimicrobial
agents, we need further efforts to identify the risk factors for
antibiotic-resistant infection.
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CS18-01 Pneumococcal Diseases in the 21st Century
Margaret Ip*. Dept. of Microbiology, Chinese University of Hong
Kong, Prince of Wales Hospital, Shatin, Hong Kong
The introduction of the 7-valent (types 4, 6B, 9V, 14, 18C, 19F
and 23F) pneumococcal conjugate vaccine has brought a signif-
icant reduction in invasive pneumococcal disease in the United
States and Europe. In the ≤ 2 years old, the incidence of pneu-
mococcal bacteraemia has decreased from 188 to 59/100,000
